TEKLA CAPITAL MANAGEMENT LLC – Regeneron Pharmaceuticals, Inc. Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$75.13M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -23.66% | -33.80K shares | -9.32M | $688.87 | 109.06K |
| Q2 2022 | share | Decrease | -2.28% | -3.33K shares | -17.65M | $591.13 | 142.86K |
| Q1 2022 | share | Increase | +2.20% | 3.15K shares | 11.77M | $698.42 | 146.2K |
| Q4 2021 | share | Decrease | -3.36% | -4.96K shares | 762K | $642.51 | 143.04K |
| Q3 2021 | share | Increase | +7.15% | 9.88K shares | 12.42M | $605.18 | 148.01K |
| Q2 2021 | share | Decrease | -10.01% | -15.37K shares | 4.52M | $558.54 | 138.13K |
| Q1 2021 | share | Decrease | -14.43% | -25.88K shares | -14.03M | $473.14 | 153.50K |
| Q4 2020 | share | Decrease | -13.50% | -28.00K shares | -29.42M | $483.11 | 179.38K |
| Q3 2020 | share | Increase | +10.35% | 19.45K shares | -1.11M | $559.78 | 207.38K |
| Q2 2020 | share | Increase | +9.98% | 17.05K shares | 33.76M | $623.65 | 187.93K |
| Q1 2020 | share | Decrease | -15.10% | -30.39K shares | 7.86M | $488.29 | 170.87K |
| Q4 2019 | share | Increase | +26.07% | 41.61K shares | 31.28M | $375.48 | 201.27K |
| Q3 2019 | share | Decrease | -4.38% | -7.31K shares | -7.97M | $277.4 | 159.65K |
| Q2 2019 | share | Increase | +17.97% | 25.43K shares | -5.85M | $313 | 166.96K |
| Q1 2019 | share | Increase | +3.75% | 5.11K shares | 7.16M | $410.62 | 141.53K |
| Q4 2018 | share | Decrease | -6.71% | -9.81K shares | -8.13M | $373.5 | 136.42K |
| Q3 2018 | share | 0.00% | 0 shares | 8.63M | $404.04 | 146.23K | |
| Q2 2018 | share | Increase | +4.78% | 6.67K shares | 2.39M | $344.99 | 146.23K |
| Q1 2018 | share | Decrease | -18.15% | -30.95K shares | -16.04M | $344.36 | 139.56K |
| Q4 2017 | share | 0.00% | 0 shares | -12.13M | $375.96 | 170.51K | |
| Q3 2017 | share | Decrease | -9.14% | -17.15K shares | -15.92M | $447.12 | 170.51K |
| Q2 2017 | share | 0.00% | 0 shares | 19.44M | $491.14 | 187.66K | |
| Q1 2017 | share | 0.00% | 0 shares | 3.83M | $387.51 | 187.66K | |
| Q4 2016 | share | Increase | +21.65% | 33.4K shares | 6.87M | $367.09 | 187.66K |
| Q3 2016 | share | 0.00% | 0 shares | 8.14M | $402.02 | 154.26K | |
| Q2 2016 | share | 0.00% | 0 shares | -1.73M | $349.23 | 154.26K | |
| Q1 2016 | share | 0.00% | 0 shares | -28.14M | $360.44 | 154.26K |